BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xavier CP, Belisario DC, Rebelo R, Assaraf YG, Giovannetti E, Kopecka J, Vasconcelos MH. The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Zhu L, Kwok HF. Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment. Drug Resist Updat 2023;66:100904. [PMID: 36462375 DOI: 10.1016/j.drup.2022.100904] [Reference Citation Analysis]
2 Giordano A, Rucci N, Falone S. Editorial: Extracellular vesicles as modulators of cancer cell adaptive responses linked to therapy resistance. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1101103] [Reference Citation Analysis]
3 Yang Q, Xu J, Gu J, Shi H, Zhang J, Zhang J, Chen ZS, Fang X, Zhu T, Zhang X. Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications. Adv Sci (Weinh) 2022;9:e2201609. [PMID: 36253096 DOI: 10.1002/advs.202201609] [Reference Citation Analysis]
4 Sun X, Zhang Y, Li H, Zhou Y, Shi S, Chen Z, He X, Zhang H, Li F, Yin J, Mou M, Wang Y, Qiu Y, Zhu F. DRESIS: the first comprehensive landscape of drug resistance information. Nucleic Acids Res 2023;51:D1263-75. [PMID: 36243960 DOI: 10.1093/nar/gkac812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Capula M, Perán M, Xu G, Donati V, Yee D, Gregori A, Assaraf YG, Giovannetti E, Deng D. Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance. Drug Resist Updat 2022;64:100864. [PMID: 36115181 DOI: 10.1016/j.drup.2022.100864] [Reference Citation Analysis]
6 Wang H, Gao X, Yu S, Wang W, Liu G, Jiang X, Sun D. Circular RNAs regulate parental gene expression: A new direction for molecular oncology research. Front Oncol 2022;12:947775. [DOI: 10.3389/fonc.2022.947775] [Reference Citation Analysis]
7 Singh D, Assaraf YG, Gacche RN. Long Non-coding RNA Mediated Drug Resistance in Breast Cancer. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Huang M, Lin Y, Wang C, Deng L, Chen M, Assaraf YG, Chen ZS, Ye W, Zhang D. New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects. Drug Resist Updat 2022;64:100849. [PMID: 35842983 DOI: 10.1016/j.drup.2022.100849] [Cited by in F6Publishing: 1] [Reference Citation Analysis]